Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity (Phase 2 Trial)
7 Future perspectives and research Future research on the relationship between CD and MetS should aim to elucidate the multifactorial mechanisms that link intestinal, metabolic, genetic, and environmental determinants
Frequency: one subcutaneous injection 5 days per week , titrating up as tolerated [5] [6]
This inhibition preserves cellular NAD+ levels by reducing their consumption, simultaneously increasing GLUT4 transporter expression and activating sirtuin 1, known as the "longevity gene." The compound exhibits high membrane permeability and selectivity without affecting related methyltransferases or NAD+ salvage pathway enzymes, creating targeted metabolic effects while maintaining cellular safety
The border of the brain in the image was marked using ImageJ software and then the surface area of the brain was measured
Real-time PCR analyses were performed using SYBR Green I PCR kit (Stratagene, La Jolla, CA, USA) via Mx 3000P instrument (Stratagene)